Mateo, College Student
More Patient Stories

MATEO

Name: Mateo
Age: 20
Age at type 1 Gaucher diagnosis: 15
Ethnicity: Hispanic
Treatment history: VPRIV, 5 years
Symptoms at baseline: Moderately low hemoglobin, mildly enlarged spleen, reduced bone density3
Last check-up: Maintained improvements in hemoglobin count and spleen volume1,4,5

*Not an actual patient. This is a hypothetical patient profile.

*Not an actual patient. This is a hypothetical patient profile.

Mateo, College Student
Name: Mateo
Age: 20
Age at type 1 Gaucher diagnosis: 15
Ethnicity: Hispanic
Treatment history: VPRIV, 5 years
Symptoms at baseline:
Moderately low hemoglobin, mildly enlarged spleen, reduced bone density3
Last check-up:
Maintained improvements in hemoglobin count and spleen volume1,4,5

Once Mateo was diagnosed with type 1 Gaucher disease as a teenager, his parents and physician came up with a treatment plan. After discussing the risks and benefits, they chose VPRIV as his treatment. Mateo received infusions at the hospital for the first 6 months and then transitioned to home infusions.4

When Mateo was 18 years old he moved away from his home in Miami, Florida, to attend university in New York City. Mateo and his parents planned for this transition and found an infusion center near his campus. He was able to schedule his infusions around his classes and settle into his new treatment schedule.

Consider
  • VPRIV can be infused in multiple settings, including at infusion centers and hospitals. Patients can also work with their HCPs to arrange for infusions to be taken at home.

  • Young adults are able to change infusion sites when going to college or moving away from home.

Looking to start your patients on VPRIV? Start the process by downloading a OnePath® Start Form and filling it in with your patients to begin. Please contact OnePath® at 1-866-888-0660 with any questions.

VPRIV OnePath® Start Form

Download the full VPRIV Patient Profiles here.

VPRIV Patient Profiles